Robin J. Steele
Independent DirectorMs. Robin J. Steele, Esq., J.D. & L.L.M., serves as Director of Nacuity Pharmaceuticals, Inc. and GLAdiator Biosciences. She served as Independent Director at Coagulant Therapeutics, Inc. Ms. Steele served as Senior Vice President, General Counsel and Corporate Secretary of InterMune, Inc. since May 17, 2004. She serves as Director at and Ancient Organics Bioscience, Inc. She served as a Director of OcuTerra Therapeutics, Inc., since 2021. Ms. Steele served as General Counsel of Array BioPharm, Inc. Ms. Steele served as InterMune's Acting General Counsel since May 2004. From 1998 to April 2003, Ms. Steele worked at Elan Pharmaceuticals, Inc. and her last position was Vice President of Commercial and Legal Affairs in San Diego. She served as an advisor to Daré since its inception in 2015. During her tenure at Elan, Ms. Steele provided legal support for over 15 marketed pharmaceutical products and was actively involved in Elan's in-licensing, partnering, co-promotion and acquisition activities. Prior to joining Elan, Ms.Steele was in private practice and served as outside counsel to a variety of life science and technology based companies in the Bay Area. She served as a Director of Alveo Technologies. She has been a Director of Daré Bioscience, Inc. since July 2017. Ms. Steele served as a Director of Targanta Therapeutics Corp. from December 2005 to December 31, 2007. She served as a Director of Alios Biopharma. Ms. Steele earned the National Association of Corporate Directors (NACD) Directorship Certification credential in 2021. Ms. Steele received a J.D from Hastings College of the Law, University of California, San Francisco, a L.L.M in Taxation from New York University School of Law and a B.A in Biology from University of Colorado, Boulder.
Positions
- Company NameDaré Bioscience, Inc.Stock CodeDAREPositionIndependent DirectorColleagues
- SMSabrina Martucci JohnsonCEO, President, Principal Financial Officer, Secretary & Director
- WHWilliam H. RastetterIndependent Chairman of the Board
- MJMarDee J. Haring-LaytonChief Accounting Officer
- MWMark WaltersVice President of Operations
- DFDavid FriendChief Scientific Officer
- JKJennifer KiangVice President of Corporate Affairs & Development
- SLSusan L. KelleyIndependent Director
- GWGregory W. MatzIndependent Director
